Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcesspositive regulation of action potential

TRPM4 FFAR3 GPR42

2.58e-0518673GO:0045760
GeneOntologyBiologicalProcesspositive regulation of acute inflammatory response to non-antigenic stimulus

FFAR3 GPR42

3.11e-053672GO:0002879
GeneOntologyBiologicalProcessregulation of acute inflammatory response to non-antigenic stimulus

FFAR3 GPR42

6.21e-054672GO:0002877
GeneOntologyBiologicalProcesspachytene

TOPAZ1 PIWIL2

6.21e-054672GO:0000239
GeneOntologyBiologicalProcessacute inflammatory response to non-antigenic stimulus

FFAR3 GPR42

1.03e-045672GO:0002525
GeneOntologyBiologicalProcessregulation of production of molecular mediator of immune response

TRPM4 SLC15A4 FFAR3 GPR42 PARP3 SIGLEC10

1.04e-04231676GO:0002700
GeneOntologyBiologicalProcesspositive regulation of neuronal action potential

FFAR3 GPR42

1.55e-046672GO:1904457
DomainARM-type_fold

SCYL2 DOCK5 USP34 PSME4 CLTC PDS5A ZNFX1 LYST TARBP1

2.86e-06339669IPR016024
DomainGPR40-rel_orph

FFAR3 GPR42

7.35e-054662IPR013312
DomainRas_G-nucl-exch_fac_CS

RASGRF1 RASGRF2

1.09e-0314662IPR019804
DomainHEAT_REPEAT

SCYL2 PSME4 PDS5A

1.95e-0370663PS50077
DomainRasGEFN

RASGRF1 RASGRF2

2.24e-0320662SM00229
DomainRasGEF_N

RASGRF1 RASGRF2

2.47e-0321662PF00618
DomainRas-like_Gua-exchang_fac_N

RASGRF1 RASGRF2

2.71e-0322662IPR000651
DomainRASGEF_NTER

RASGRF1 RASGRF2

2.71e-0322662PS50212
DomainIQ

RASGRF1 RASGRF2 MYO3B

2.95e-0381663SM00015
DomainActinin_actin-bd_CS

PLEC PLS3

2.97e-0323662IPR001589
DomainACTININ_2

PLEC PLS3

2.97e-0323662PS00020
DomainACTININ_1

PLEC PLS3

2.97e-0323662PS00019
DomainRASGEF

RASGRF1 RASGRF2

3.78e-0326662PS00720
DomainIQ_motif_EF-hand-BS

RASGRF1 RASGRF2 MYO3B

3.98e-0390663IPR000048
DomainIQ

RASGRF1 RASGRF2 MYO3B

4.36e-0393663PS50096
DomainRASGEF_CAT

RASGRF1 RASGRF2

4.70e-0329662PS50009
DomainRasGEF

RASGRF1 RASGRF2

5.02e-0330662PF00617
Domain-

RASGRF1 RASGRF2

5.02e-03306621.10.840.10
DomainRas_GEF_dom

RASGRF1 RASGRF2

5.02e-0330662IPR023578
DomainRASGEF_cat_dom

RASGRF1 RASGRF2

5.02e-0330662IPR001895
DomainRasGEF

RASGRF1 RASGRF2

5.02e-0330662SM00147
Domain7tm_1

OR4S1 FFAR3 GPR42 OR6C1 CCR1 OR2S2 OR6P1

9.74e-03677667PF00001
DomainG_PROTEIN_RECEP_F1_1

OR4S1 FFAR3 GPR42 OR6C1 CCR1 OR2S2 OR6P1

1.03e-02685667PS00237
Pubmed

RASGRF2 controls nuclear migration in postnatal retinal cone photoreceptors.

RASGRF1 RASGRF2

3.66e-06267226743081
Pubmed

Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia.

FFAR3 GPR42

3.66e-06267225637492
Pubmed

Selective tracking of FFAR3-expressing neurons supports receptor coupling to N-type calcium channels in mouse sympathetic neurons.

FFAR3 GPR42

3.66e-06267230478340
Pubmed

3-(4-Hydroxy-3-methoxyphenyl) propionic acid contributes to improved hepatic lipid metabolism via GPR41.

FFAR3 GPR42

3.66e-06267238040866
Pubmed

Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer's Disease Mouse Model.

FFAR3 GPR42

3.66e-06267235408893
Pubmed

FFAR3 modulates insulin secretion and global gene expression in mouse islets.

FFAR3 GPR42

3.66e-06267226091414
Pubmed

GPR41 modulates insulin secretion and gene expression in pancreatic β-cells and modifies metabolic homeostasis in fed and fasting states.

FFAR3 GPR42

3.66e-06267227550964
Pubmed

Intestinal FFA3 mediates obesogenic effects in mice on a Western diet.

FFAR3 GPR42

3.66e-06267235858247
Pubmed

Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms.

FFAR3 GPR42

3.66e-06267222506074
Pubmed

Free fatty acid receptor 3 differentially contributes to β-cell compensation under high-fat diet and streptozotocin stress.

FFAR3 GPR42

3.66e-06267232073900
Pubmed

Distinct roles for Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and Ras-GRF2 in the induction of long-term potentiation and long-term depression.

RASGRF1 RASGRF2

3.66e-06267216467520
Pubmed

The effects of propionate and valerate on insulin responsiveness for glucose uptake in 3T3-L1 adipocytes and C2C12 myotubes via G protein-coupled receptor 41.

FFAR3 GPR42

3.66e-06267224748202
Pubmed

The Cognitive Improvement and Alleviation of Brain Hypermetabolism Caused by FFAR3 Ablation in Tg2576 Mice Is Persistent under Diet-Induced Obesity.

FFAR3 GPR42

3.66e-06267236362376
Pubmed

Ras-GRF2 regulates nestin-positive stem cell density and onset of differentiation during adult neurogenesis in the mouse dentate gyrus.

RASGRF1 RASGRF2

3.66e-06267228966131
Pubmed

The environment versus genetics in controlling the contribution of MAP kinases to synaptic plasticity.

RASGRF1 RASGRF2

3.66e-06267217141611
Pubmed

Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids.

FFAR3 GPR42

3.66e-06267220399779
Pubmed

Sequence polymorphisms provide a common consensus sequence for GPR41 and GPR42.

FFAR3 GPR42

3.66e-06267219630535
Pubmed

The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice.

RASGRF1 RASGRF2

3.66e-06267231182637
Pubmed

Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content.

FFAR3 GPR42

3.66e-06267223110765
Pubmed

The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation.

FFAR3 GPR42

3.66e-06267226522986
Pubmed

Transgenerational rescue of a genetic defect in long-term potentiation and memory formation by juvenile enrichment.

RASGRF1 RASGRF2

3.66e-06267219193896
Pubmed

Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41.

FFAR3 GPR42

3.66e-06267214722361
Pubmed

Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41.

FFAR3 GPR42

3.66e-06267227664183
Pubmed

Activation of H-Ras in the endoplasmic reticulum by the RasGRF family guanine nucleotide exchange factors.

RASGRF1 RASGRF2

3.66e-06267214749369
Pubmed

A murine CDC25/ras-GRF-related protein implicated in Ras regulation.

RASGRF1 RASGRF2

3.66e-0626728293576
Pubmed

Human GPR42 is a transcribed multisite variant that exhibits copy number polymorphism and is functional when heterologously expressed.

FFAR3 GPR42

3.66e-06267226260360
Pubmed

G protein coupled receptor 41 regulates fibroblast activation in pulmonary fibrosis via Gαi/o and downstream Smad2/3 and ERK1/2 phosphorylation.

FFAR3 GPR42

3.66e-06267237019194
Pubmed

Short-chain fatty acid receptor GPR41-mediated activation of sympathetic neurons involves synapsin 2b phosphorylation.

FFAR3 GPR42

1.10e-05367222673524
Pubmed

RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation.

RASGRF1 RASGRF2

1.10e-05367221685891
Pubmed

The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.

FFAR3 GPR42

1.10e-05367212496283
Pubmed

Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.

FFAR3 GPR42

1.10e-05367223665276
Pubmed

Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer.

FFAR3 GPR42

1.10e-05367234210970
Pubmed

Spinal cord repair: future directions.

SCYL2 CLTC

1.10e-0536721589293
Pubmed

Dietary short-chain fatty acid intake improves the hepatic metabolic condition via FFAR3.

FFAR3 GPR42

1.10e-05367231719611
Pubmed

Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43.

FFAR3 GPR42

1.10e-05367216123168
Pubmed

GPR41 gene expression is mediated by internal ribosome entry site (IRES)-dependent translation of bicistronic mRNA encoding GPR40 and GPR41 proteins.

FFAR3 GPR42

1.10e-05367222493486
Pubmed

Targeted disruption of Ras-Grf2 shows its dispensability for mouse growth and development.

RASGRF1 RASGRF2

1.10e-05367211909944
Pubmed

Extracellular ionic locks determine variation in constitutive activity and ligand potency between species orthologs of the free fatty acid receptors FFA2 and FFA3.

FFAR3 GPR42

1.10e-05367223066016
Pubmed

Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes.

FFAR3 GPR42

1.10e-05367225581519
Pubmed

[Analysis of deafness gene mutations by gene chip and its clinical significance].

SLC26A4 PDS5A

1.10e-05367220359100
Pubmed

Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2.

FFAR3 GPR42

1.10e-05367222190648
Pubmed

Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8+ T Cells.

FFAR3 GPR42

1.10e-05367231272808
Pubmed

GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes.

FFAR3 GPR42

1.10e-05367223885020
Pubmed

Dietary Fiber Confers Protection against Flu by Shaping Ly6c- Patrolling Monocyte Hematopoiesis and CD8+ T Cell Metabolism.

FFAR3 GPR42

1.10e-05367229768180
Pubmed

Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41.

FFAR3 GPR42

1.10e-05367218931303
Pubmed

GPR41 and GPR43 regulate CD8+ T cell priming during herpes simplex virus type 1 infection.

FFAR3 GPR42

1.10e-05367238524121
Pubmed

Abnormalities in microbiota/butyrate/FFAR3 signaling in aging gut impair brain function.

FFAR3 GPR42

1.10e-05367238329121
Pubmed

Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB.

RASGRF1 RASGRF2

1.10e-05367215029245
Pubmed

Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation.

FFAR3 GPR42

2.19e-05467223401498
Pubmed

A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1.

FFAR3 GPR42

2.19e-0546729344866
Pubmed

Characterization of murine CD70 by molecular cloning and mAb.

TFEB LAMA1

2.19e-0546729620608
Pubmed

iPS cells from Chediak-Higashi syndrome patients recapitulate the giant granules in myeloid cells.

MPO LYST

2.19e-05467236259166
Pubmed

Structural and spatial determinants regulating TC21 activation by RasGRF family nucleotide exchange factors.

RASGRF1 RASGRF2

2.19e-05467219692568
Pubmed

Role for piRNAs and noncoding RNA in de novo DNA methylation of the imprinted mouse Rasgrf1 locus.

RASGRF1 PIWIL2

2.19e-05467221566194
Pubmed

Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41).

FFAR3 GPR42

2.19e-05467221518883
Pubmed

RasGRF Couples Nox4-Dependent Endoplasmic Reticulum Signaling to Ras.

RASGRF1 RASGRF2

2.19e-05467227856453
Pubmed

A family of fatty acid binding receptors.

FFAR3 GPR42

2.19e-05467215684720
Pubmed

Maternal High Fiber Diet during Pregnancy and Lactation Influences Regulatory T Cell Differentiation in Offspring in Mice.

FFAR3 GPR42

2.19e-05467229021375
Pubmed

Microbial metabolites, short-chain fatty acids, restrain tissue bacterial load, chronic inflammation, and associated cancer in the colon of mice.

FFAR3 GPR42

2.19e-05467229644622
Pubmed

Ras-guanine-nucleotide-releasing factors 1 and 2 interact with PLCγ at focal adhesions to enable IL-1-induced Ca(2+) signalling, ERK activation and MMP-3 expression.

RASGRF1 RASGRF2

2.19e-05467223145787
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

SCYL2 LRPPRC CLTC PDS5A PLEC DCTN1 PLS3 HELLS

3.09e-0563867833239621
Pubmed

Fatty acid binding receptors and their physiological role in type 2 diabetes.

FFAR3 GPR42

3.64e-05567219009545
Pubmed

Dispersed DNA variants underlie hearing loss in South Florida's minority population.

SLC26A4 STRC

3.64e-05567237996878
Pubmed

Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells.

FFAR3 GPR42

3.64e-05567224327954
Pubmed

Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81.

FFAR3 GPR42

3.64e-05567219047060
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

TFEB USP34 TRPM4 ABCA2 PSME4 USP40 PLEC ESPL1 DCTN1 LYST

4.83e-051105671035748872
Pubmed

Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis.

FFAR3 GPR42

5.46e-05667219460454
Pubmed

The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.

USP34 TRPM4 LRPPRC PSME4 PDS5A

5.70e-0521267533853758
Pubmed

Long-term potentiation in the CA1 hippocampus induced by NR2A subunit-containing NMDA glutamate receptors is mediated by Ras-GRF2/Erk map kinase signaling.

RASGRF1 RASGRF2

7.63e-05767220661302
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

DOCK5 TOPAZ1 MYO3B CLTC LAMA1 PDS5A PIWIL2 DNAH14

8.40e-0573667829676528
Pubmed

Vagal neuron expression of the microbiota-derived metabolite receptor, free fatty acid receptor (FFAR3), is necessary for normal feeding behavior.

FFAR3 GPR42

1.02e-04867234626852
Pubmed

TFEB induces mitochondrial itaconate synthesis to suppress bacterial growth in macrophages.

TFEB LYST

1.02e-04867235864246
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

SCYL2 USP34 ABCA2 TMEM168 CLTC ZNFX1 PLEC WDR17 DCTN1 TARBP1

1.67e-041285671035914814
Pubmed

Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.

LRPPRC CLTC PDS5A PLEC HELLS

1.83e-0427267531010829
Pubmed

Systematic Determination of Human Cyclin Dependent Kinase (CDK)-9 Interactome Identifies Novel Functions in RNA Splicing Mediated by the DEAD Box (DDX)-5/17 RNA Helicases.

DOCK5 AGR2 CLTC PLEC PLS3

2.67e-0429567526209609
Pubmed

A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci.

USP34 ACSL6 USP40

3.13e-046867322412388
Pubmed

Ras-specific exchange factor GRF: oligomerization through its Dbl homology domain and calcium-dependent activation of Raf.

RASGRF1 RASGRF2

3.28e-041467210373510
Pubmed

Role of the AP2 beta-appendage hub in recruiting partners for clathrin-coated vesicle assembly.

SCYL2 CLTC

3.28e-041467216903783
Pubmed

APache Is an AP2-Interacting Protein Involved in Synaptic Vesicle Trafficking and Neuronal Development.

CLTC DCTN1

3.28e-041467229262337
Pubmed

Microbiota modulate sympathetic neurons via a gut-brain circuit.

FFAR3 GPR42

3.78e-041567232641826
Pubmed

The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1.

RASGRF1 RASGRF2

3.78e-041567214622581
Pubmed

The Ciliopathy Protein CC2D2A Associates with NINL and Functions in RAB8-MICAL3-Regulated Vesicle Trafficking.

LRPPRC CLTC DCTN1 PLS3

3.87e-0417767426485645
Pubmed

Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.

SCYL2 MPO DOCK5 USP40 UTP3 PLEC

3.90e-0449667631343991
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

LRPPRC RASGRF2 CLTC MED12L PLEC DCTN1

3.95e-0449767623414517
Pubmed

An approach based on a genome-wide association study reveals candidate loci for narcolepsy.

MPO CTNNAL1 OR6C1 OR2S2

5.36e-0419367420677014
Pubmed

Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice.

CLTC PLEC

6.12e-041967232888949
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

DOCK5 CLTC ZNFX1 PLEC

6.36e-0420267433005030
Pubmed

RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

LRPPRC KIDINS220 CLTC DCTN1

6.36e-0420267424639526
Pubmed

Cytoplasmic cleavage of DPPA3 is required for intracellular trafficking and cleavage-stage development in mice.

TFEB CLTC

6.79e-042067229158485
Pubmed

Large-scale mapping of human protein-protein interactions by mass spectrometry.

LIG4 LRPPRC RASGRF2 PARP3 CLTC PDS5A DCTN1 PLS3 HELLS

7.72e-04128467917353931
Pubmed

Proteome analysis of the circadian clock protein PERIOD2.

LRPPRC CLTC PLEC

8.08e-049467335122331
Pubmed

Diverse functions of myosin VI elucidated by an isoform-specific α-helix domain.

CLTC DCTN1

8.24e-042267226950368
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

SCYL2 DOCK5 MED12L PLEC DCTN1 HELLS

9.00e-0458267620467437
Pubmed

Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases.

USP34 USP40

9.01e-042367214715245
Pubmed

GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer.

SCYL2 LRPPRC SGPL1 CLTC

9.19e-0422367433731348
Pubmed

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.

LRPPRC SGPL1 CLTC PLEC DCTN1 HELLS

1.06e-0360167633658012
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

USP34 CTNNAL1 PSME4 SGPL1 CLTC PLEC ESPL1 DCTN1

1.11e-03108467811544199
Pubmed

Identification of proteins associated with ligand-activated estrogen receptor α in human breast cancer cell nuclei by tandem affinity purification and nano LC-MS/MS.

SCYL2 CLTC UTP3 PLEC

1.30e-0324567421182205
Pubmed

TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma.

SCYL2 CLTC

1.34e-032867229653964
Pubmed

Gene expression and dental enamel structure in developing mouse incisor.

AMBN LAMA1

1.44e-032967220487000
Cytoband12q23.1

SCYL2 CFAP54

1.08e-033367212q23.1
Cytoband19q13.1

FFAR3 GPR42

2.96e-035567219q13.1
GeneFamilyDyneins, axonemal

DNAH17 DNAH14

9.15e-0417482536
ToppCellSevere-CD8+_T_activated|Severe / Disease group and Cell class

DOCK5 GPR155 ABCA2 CCR1 JAML LYST

4.77e-07197666bb1e3e1d841c2c7141eb1099e7755860b168b6fc
ToppCellmedial-Hematologic-Intermediate_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MPO FFAR3 SIGLEC10 CCR1 JAML LYST

4.91e-07198666dbd7869483c5a67944cb94ced0ee2c7b999adc2e
ToppCellmedial-Hematologic-Intermediate_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MPO FFAR3 SIGLEC10 CCR1 JAML LYST

4.91e-071986668f64bb5cd8c3e2d5ef651821b0d59f67d1ca1a12
ToppCellmedial-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MPO FFAR3 SIGLEC10 CCR1 JAML LYST

4.91e-07198666432a26ace5b486695c9a933c0d44b73305b01ded
ToppCellfacs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TOPAZ1 MED12L CCR1 JAML LYST

4.52e-061646658e6dbddacd56a07769163813e3ebfad13302bb62
ToppCell3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue

DOCK5 TRPM4 LAMA1 SIGLEC10 JAML

6.37e-0617666572a3bbab0540ae3e3c94b9573cdb9298a024dbc4
ToppCellTCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9

RASGRF1 SLC15A4 CLTC LAMA1 LYST

7.30e-061816659d5b331cabc5524f0a9fd8b571e87be4c447c7d4
ToppCellIPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class

DOCK5 FFAR3 GPR42 SIGLEC10 LYST

9.01e-061896655c22d2d935f7bb270260b8bc6be67b565ec401bf
ToppCellMild-CD8+_T_activated|World / Disease group and Cell class

GPR155 CCR1 ZNFX1 JAML TARBP1

1.07e-0519666579632190e44fcef9d7c11d9b9e37f2ebf0e6e255
ToppCellSepsis-URO-Lymphocyte-T/NK-MAIT|URO / Disease, condition lineage and cell class

RASGRF2 CTDSPL2 SLC26A4 MYO3B DNAH14

1.13e-0519866575db638278d4be2b0f406cd8871058a8352c5a86
ToppCellmild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2)

CTNNAL1 TEDC2 ESPL1 PLS3 HELLS

1.16e-05199665d44cc74d7171d96add61dae821daf774b17d4c69
ToppCellFrontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Calb1_(Superficial_layer_pyramidal_cells--Layer_2/3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

SPATA21 DEFB128 A4GNT PKD1L2

3.69e-051266647dcc79bf35482e8e5e5a1de7279ba080edb70522
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Pvalb_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

TOPAZ1 SPATA21 PIWIL2

5.97e-055166328d6b12c44ad308560931d275e0dd0243a555bf3
ToppCellpdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

SCYL2 CTNNAL1 PSME4 ZNFX1

6.22e-051446640b94d978262a826c9254145aa98c6c30240243f9
ToppCellMyeloid-E_(Neutrophils)|World / shred on cell class and cell subclass (v4)

MED12L CCR1 JAML LYST

6.39e-051456646ae7dbc62116b4d0610fb55703679488e8da4733
ToppCellPND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MED12L CCR1 JAML LYST

7.10e-051496642a2a5673ce4f376e7b25f2bc8127fb7e260f37af
ToppCellPND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MED12L CCR1 JAML LYST

7.10e-05149664c9f02ec62a658a751e591699f9395fe597e22a2e
ToppCellfacs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK5 CCR1 PLEC JAML

8.69e-051576649d4308312301cb922f156a7b6aededc9e1c62807
ToppCellnormal_Lung-B_lymphocytes-Undetermined|normal_Lung / Location, Cell class and cell subclass

TFEB RASGRF2 FFAR3 GPR42

9.13e-05159664f89fc18966d9b9b33e81e7b9eb3ec3420c20ff43
ToppCelldroplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LETM2 RASGRF2 MED12L ESPL1

1.05e-04165664c39f0479955c4e23921f7a450d3bc251a002200f
ToppCellPND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LETM2 CTNNAL1 TEDC2 PLEC

1.13e-0416866432e4d82efaccf336d347e4063253c3635a3ec672
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CTNNAL1 RASGRF1 CLTC HELLS

1.13e-0416866408f6e171a1ea5cf65149744296d0fcd6c7b9684e
ToppCellCOVID-mDC1-|COVID / Condition, Cell_class and T cell subcluster

RASGRF1 SIGLEC10 MED12L PLS3

1.32e-0417566483a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15
ToppCellE18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

GPR155 TFEB ABCA2 RASGRF2

1.32e-04175664711ace94fa9a763c6ae48171a690953f25deebe4
ToppCellCOVID-mDC1|COVID / Condition, Cell_class and T cell subcluster

RASGRF1 SIGLEC10 MED12L PLS3

1.32e-04175664b9280444016e21c28131a61df65cc5c56d402412
ToppCell3'_v3-lymph-node_spleen-Hematopoietic_progenitors-HSC-MPP|lymph-node_spleen / Manually curated celltypes from each tissue

MPO TEDC2 MED12L PLS3

1.35e-0417666432ed5623b8809b9f1aaf7a42dff9807d9376e9c2
ToppCell3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TFEB SIGLEC10 CCR1 JAML

1.44e-04179664ce95b601bf17ae8167d382a105384b9e65e9407f
ToppCellLPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK5 CCR1 JAML LYST

1.54e-04182664243c783675df495ea4112dbf710712c44ea6b4f1
ToppCellLPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK5 CCR1 JAML LYST

1.54e-0418266418790a394dc32b3cef99cdbf826392c520e38b4a
ToppCellsevere-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

DOCK5 SLC15A4 SIGLEC10 JAML

1.57e-0418366460a6112aa4fc4f5debda4c7e81b37539ba2e4e6e
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TFEB SLC15A4 SIGLEC10 CCR1

1.60e-0418466495cf125127658c4c04445c61809d1aed21ee1f83
ToppCellPCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

AGR2 SIGLEC10 CCR1 JAML

1.67e-0418666473185d48c874e18dd2e2eeea67c32d3182ea88a5
ToppCell3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TFEB SIGLEC10 CCR1 JAML

1.67e-04186664bec4767eaca28e41da373274704895eba75063e2
ToppCellPCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

RASGRF1 AGR2 CCR1 JAML

1.67e-041866646575ec6a626cdea169ffd185d47828dfaa29475d
ToppCellPCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

AGR2 SIGLEC10 CCR1 JAML

1.74e-041886648fc15c8b78fdd1a578e34325011bc5a87a8aab31
ToppCelldroplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MPO TEDC2 ALG8 HELLS

1.81e-04190664638bebe200249ff6f7be764d89bd762da39ebaae
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USP34 PSME4 CTDSPL2 PDS5A

1.85e-0419166460c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue

MPO TEDC2 ESPL1 HELLS

1.85e-04191664e642fa7395c05fb53324c9d46bbc52f89fc9673f
ToppCell10x5'-Lung-Myeloid_Monocytic-Nonclassical_monocytes|Lung / Manually curated celltypes from each tissue

DOCK5 FFAR3 SIGLEC10 LYST

1.85e-04191664a862a571625ab7238589ff201e5954f602c3bd7e
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CTNNAL1 MYO3B LAMA1 DNAH14

1.85e-041916649032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USP34 PSME4 CTDSPL2 PDS5A

1.85e-0419166409db184cb90fe282a14474d7217068c58092c6f8
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CTNNAL1 MYO3B LAMA1 DNAH14

1.85e-041916645717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USP34 PSME4 CTDSPL2 PDS5A

1.85e-04191664973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCellT_cells-Central_memory_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis

GPR155 ACSL6 RASGRF2 JAML

1.85e-0419166425dd538d6a361bd3367c8a1c0dfc9e7003061af3
ToppCellCOVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type

DOCK5 CCR1 JAML LYST

1.88e-04192664441cd1ec171f643b28e1f6f9c04def629cc7391b
ToppCellIPF-Myeloid-ncMonocyte|IPF / Disease state, Lineage and Cell class

DOCK5 FFAR3 GPR42 SIGLEC10

1.88e-04192664e9fb8c57d8094f70fb492909b2bec40aa5f2e5b8
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FFAR3 GPR42 SIGLEC10 LYST

1.92e-04193664cb0fb21510124883e716780bea46575620c366b8
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

USP34 LRPPRC CLTC PDS5A

1.92e-04193664abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

DOCK5 PSME4 JAML LYST

1.92e-04193664778fcf8448e81fe18972d97ea8a30ab036d16fe5
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FFAR3 GPR42 SIGLEC10 LYST

1.92e-041936640c207879f994c227dcd1322faa69ec9e3749cdaa
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FFAR3 GPR42 SIGLEC10 LYST

1.92e-041936640fbbfcc803edc3cd96b35467ad5cc573af07fd67
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CTNNAL1 TEDC2 ESPL1 HELLS

1.96e-04194664f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCell3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue

CTNNAL1 TEDC2 ESPL1 HELLS

1.96e-04194664a8ae49157ca3f9e8b3f1750a995aee012dc859b6
ToppCell3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue

CTNNAL1 TEDC2 ESPL1 HELLS

1.96e-04194664bf9734abaad603ade2a6a6940918aaf1e1c4e2cd
ToppCellControl-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class

CTNNAL1 TEDC2 ESPL1 HELLS

1.96e-041946649bbb124001fba7450f4639f47f9b720a483e7242
ToppCellPCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

MPO AGR2 CCR1 JAML

1.96e-0419466485c5d07189eb7bb413f708a3ca40de08af3cb106
ToppCellILEUM-inflamed-(3)_moDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

DOCK5 SIGLEC10 CCR1 JAML

1.96e-04194664c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43
ToppCelldistal-2-Hematologic-Myeloid_Dendritic_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

DOCK5 SIGLEC10 MED12L JAML

1.96e-041946646881cfe12837a32e598535a564e4c31d4846167b
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CTNNAL1 TEDC2 ESPL1 HELLS

1.96e-04194664a75ecd0b0a928d4646602f7d16a645f6b3df3af5
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CTNNAL1 TEDC2 ESPL1 HELLS

1.96e-0419466417744fd6645cf5a447a01a83f07e8d305c2bcd9c
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CTNNAL1 TEDC2 ESPL1 HELLS

1.96e-04194664e14f66f7584909621b776292fbd52808273fd2ee
ToppCellPCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_dendritic_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

AGR2 SIGLEC10 CCR1 JAML

2.00e-041956644387e27d2288fb46a9ed110464542a4aea402358
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK5 SIGLEC10 JAML LYST

2.00e-041956641d58585557bf8e9ce4d514e128d3a902b526331d
ToppCellInfluenza_Severe-T/NK_proliferative|World / Disease group and Cell class

CTNNAL1 TEDC2 ESPL1 HELLS

2.00e-041956646f079c2d7d08110a5e1822ea861b8037eb3f62c9
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FFAR3 SIGLEC10 CCR1 LYST

2.00e-0419566401da7115e38c280fb0baff2032b62bdb609bad5e
ToppCellHealthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class

CTNNAL1 TEDC2 ESPL1 HELLS

2.00e-04195664957458fdc39723f4a31bd7fd3ce32891aa3fd462
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells)

TEDC2 ESPL1 JAML HELLS

2.00e-0419566447a01b8a92eebeb34ac7f70bf1ab4613a326e24f
ToppCellHealthy-T/NK_proliferative|Healthy / disease group, cell group and cell class

CTNNAL1 TEDC2 ESPL1 HELLS

2.04e-0419666491e44aabb2e85dcc77ddae6f7e000118d45d1de6
ToppCellControl-T/NK_proliferative|Control / Disease condition and Cell class

CTNNAL1 TEDC2 ESPL1 HELLS

2.04e-041966647b7bc25aef49bfd64f79303a92d527bf8188f7a6
ToppCellsevere_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2)

CTNNAL1 TEDC2 PLS3 HELLS

2.08e-04197664189d97a6c2ff8803db8cc05e205c9d88dac3911f
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CTNNAL1 TEDC2 ESPL1 HELLS

2.08e-041976644b13335a43b9d6abc8e542e72440da7feb82fbe6
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CLTC SIGLEC10 CCR1 PLEC

2.08e-04197664e2c53742c7d8d1b63d93843f82330b9e20f1faa6
ToppCellHealthy/Control-T/NK_proliferative|World / Disease group and Cell class

CTNNAL1 TEDC2 ESPL1 HELLS

2.08e-041976644a4d3083938783d6f5b87da02f10e501917da0b4
ToppCellBAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CTNNAL1 TEDC2 ESPL1 HELLS

2.08e-04197664d7a9296092153cf66426911fecd810f0c1ef978e
ToppCellBAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CTNNAL1 TEDC2 ESPL1 HELLS

2.08e-04197664dcff23240bb7cb652d7426b29355aa74442ef6fc
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CTNNAL1 TEDC2 ESPL1 HELLS

2.08e-0419766421861d8b389fafbdb7c3499684c9b6deee3dbd5e
ToppCellMild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass

CTNNAL1 TEDC2 ESPL1 HELLS

2.08e-04197664794517c70089da109f4c6489fe406c0ba6882b76
ToppCellBAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CTNNAL1 TEDC2 ESPL1 HELLS

2.08e-04197664f34b1e34f1f0694564031077172c890b233ce8b7
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CLTC SIGLEC10 CCR1 PLEC

2.08e-041976649838dbd1623babf8de7e9126a28fe5d3666bce42
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CTNNAL1 TEDC2 ESPL1 HELLS

2.08e-04197664ffb004c37cdd26cb7cdcd80f769a2eded65416dc
ToppCellHealthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2)

CTNNAL1 TEDC2 ESPL1 HELLS

2.08e-04197664b6bbf87e5823fa66b4cad6a7be4f777356887b59
ToppCell10x3'2.3-week_17-19-Myeloid_monocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

MPO CCR1 JAML LYST

2.12e-04198664100091c91fde604daf110f20b44505f240f93ae8
ToppCellSevere-CD8+_T_activated|World / Disease group and Cell class

DOCK5 ABCA2 CCR1 LYST

2.12e-041986645ff98c9b6c8c6863767b76c7745f263568f86acc
ToppCellPCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

AGR2 SIGLEC10 CCR1 JAML

2.12e-041986641d242fbe4ae3628103f6b6f910a7641bb1b75266
ToppCellMild-CD8+_T_activated|Mild / Disease group and Cell class

GPR155 CCR1 ZNFX1 LYST

2.12e-04198664ceac1b51bacfd0dd7fe7c6a666f7927055e1f380
ToppCellnormal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass

CTNNAL1 TEDC2 ESPL1 HELLS

2.12e-0419866447d572b9db2843aeb2079f33a852babf67270be4
ToppCell10x3'2.3-week_17-19-Myeloid_monocytic-monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

MPO CCR1 JAML LYST

2.12e-0419866473e9ada6998c09ae3a3a66e920b28694b7f9cf6b
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CTNNAL1 TEDC2 ESPL1 HELLS

2.16e-0419966411c3d9fe811a4619347f47d2b0e94066e3085625
ToppCellSepsis-ICU-NoSEP-Myeloid-tDC|ICU-NoSEP / Disease, condition lineage and cell class

TRPM4 SLC26A4 MED12L SFXN2

2.16e-0419966490ddd686b8f39c6f6134b9b048396cebcf8d0448
ToppCelldistal-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

FFAR3 SIGLEC10 JAML LYST

2.16e-041996645e209df67cfe8ac7437cc363f1c5c3166bfae1af
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CTNNAL1 TEDC2 ESPL1 HELLS

2.16e-0419966436c80907b2ec1cbcd1b4e841e6c02a4792591d74
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

CTNNAL1 TEDC2 ESPL1 HELLS

2.16e-04199664bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c
ToppCellCOVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class

CTNNAL1 TEDC2 ESPL1 HELLS

2.16e-04199664ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CTNNAL1 TEDC2 ESPL1 HELLS

2.16e-041996647beb0e07a27fea94674f24eb61c381b0de38ed3e
ToppCellnormal_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass

CTNNAL1 TEDC2 ESPL1 HELLS

2.16e-041996644142d5b1b20212508f95841fdac4efb7655616cb
ToppCellCOVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class

CTNNAL1 TEDC2 ESPL1 HELLS

2.16e-041996649f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7
ToppCellmild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2)

CTNNAL1 TEDC2 ESPL1 HELLS

2.16e-04199664df2fcaf01b1b48632f84e7355ef21d20853f0664
ToppCell(1)_T_cells-(1)_T_cell_dividing|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)

CTNNAL1 TEDC2 ESPL1 HELLS

2.16e-0419966433afdd1b1b951b360ababf440bc556fd9e1c1db2
ToppCellmild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

DOCK5 CCR1 PLEC LYST

2.20e-04200664934c2efc780318c66d667ca75be0de350361d351
ToppCellhealthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass

CTNNAL1 TEDC2 ESPL1 HELLS

2.20e-04200664e4eb915c29909cf8535a3603c68976545c05e54b
DiseaseMiT family translocation renal cell carcinoma

TFEB CLTC

1.03e-047662C4518356
DiseaseParkinsonian Disorders

DCTN1 LYST

2.06e-0330662C0242422
Diseasebowel opening frequency

FFAR3 GPR42

2.06e-0330662EFO_0600084

Protein segments in the cluster

PeptideGeneStartEntry
LKDLLDQILMLDPAK

PRPF4B

976

Q13523
MEKIPVSAFLLLVAL

AGR2

1

O95994
DLTLLIAMEPLINVK

CFAP54

526

Q96N23
ELLKLIPFLEKLVEL

CTDSPL2

431

Q05D32
VLVLLLMPRLICKAE

DCTN1

606

Q14203
IEMLLKAELPLVFSA

TBC1D32

1131

Q96NH3
IPLFKMKDLILILCL

AMBN

6

Q9NP70
DMPLLELKDIVLYLC

ASCC2

236

Q9H1I8
IDNVFLFPLDMKRLL

A4GNT

111

Q9UNA3
FLIIFPALMLLLKLH

OR6C1

151

Q96RD1
VKLLLPLEYMAIFAL

PDS5A

941

Q29RF7
PELLQAKKDMLLVLA

PARP3

276

Q9Y6F1
LSKNFLDPKELMELL

HELLS

761

Q9NRZ9
LELLLKLMFVNPPEL

KIDINS220

571

Q9ULH0
EFLLPVFLKLFPEML

LETM2

191

Q2VYF4
DDDLLKLLLPLMLQY

MED12L

266

Q86YW9
KLLVLPLLCREMVEL

GPR155

286

Q7Z3F1
LEELMKLSPEELLLR

PLS3

261

P13797
DKLIILFNIVMPPLL

OR4S1

266

Q8NGB4
EMKLLLALAGLLAIL

MPO

26

P05164
PDAMNLILLLVTEKL

LRPPRC

336

P42704
HPELEKTFFVLILLM

OR2S2

21

Q9NQN1
DLLLLLFLPFRMVEA

GPR42

61

O15529
GEIVDLLLMKILSFL

PKD1L2

2411

Q7Z442
ELVDFLLALVMILLP

OR6P1

196

Q8NGX9
VAKPMQALEVLLLLR

ESPL1

786

Q14674
VELLKRLIALQMPLL

DOCK5

1586

Q9H7D0
DDKLMLLLEINKLIP

CTNNAL1

651

Q9UBT7
ETMLAKLYIELLNLP

LIG4

86

P49917
FMPIVLELIPLKIFE

MT-CO2

206

P00403
VLYLKPLRILLEEME

DNAH17

286

Q9UFH2
LKLNLFGLVLPLLVM

CCR1

201

P32246
MKLFLVLIILLFEVL

DEFB128

1

Q7Z7B8
DLLLLLFLPFRMVEA

FFAR3

61

O14843
LLKLELPDYVRLAML

C1orf112

656

Q9NSG2
LFRMEELLLAPALLE

ABCA2

221

Q9BZC7
ELVMEILSDLLKRLP

DNAH14

3136

Q0VDD8
LILPDVLLEDVMDKL

LYST

2316

Q99698
LKMLRKESPELLELI

UTP3

216

Q9NQZ2
MFDAVLILLLIPLKD

SLC15A4

371

Q8N697
KDLDLMLLDDSLLPL

TFEB

431

P19484
ILLPVIMERLEKLHF

SFXN2

241

Q96NB2
LFEILSLLVEMLALP

SPATA21

311

Q7Z572
IHLEKVLMAELLPLV

TEDC2

381

Q7L2K0
LLKGEILLLPELSFM

PIWIL2

486

Q8TC59
ILADLFDILLPMLNI

RASGRF2

321

O14827
MFCPLKLILLPVLLD

JAML

1

Q86YT9
LFDRLKPLKMLEENL

LAMA1

2081

P25391
EPIQILLIFLQKMDL

SCYL2

421

Q6P3W7
DLLLMIPDNELHLIK

WDR17

1041

Q8IZU2
TLVLADLFDILLPML

RASGRF1

316

Q13972
LAMTALDVIFKPELL

PM20D2

401

Q8IYS1
LDSKLLLDLPIQLMD

STRC

1256

Q7RTU9
LLMLKAFEPYLEILE

SGPL1

6

O95470
LFTAPELPIKILLML

ALG8

421

Q9BVK2
ELPIKILLMLLFTIY

ALG8

426

Q9BVK2
LKLIILMDPFEEALK

ACSL6

221

Q9UKU0
YLEFKPLLLNDLLMV

CLTC

1411

Q00610
TLLFLIMLVLKLDEK

TMEM60

16

Q9H2L4
VMIAILALGKLLEPL

SLC26A4

431

O43511
IIDLRMKSFLAIPNL

TMEM168

191

Q9H0V1
LKKDLLPSDMAVALL

PLEC

3181

Q15149
LLYELVSIPKLEISM

PSME4

101

Q14997
QLLPEDFLMLKEKLA

ZNFX1

1676

Q9P2E3
KLLLIPSYLSEIEML

TOPAZ1

1576

Q8N9V7
NVLRIFLDPLLDVLM

TARBP1

661

Q13395
PAALEKMIALVALLV

USP34

2511

Q70CQ2
LLFLCLALIIMKILP

SIGLEC10

561

Q96LC7
IDHPLMILKAILLEE

USP40

341

Q9NVE5
IPVLLLLIDGDEKML

TRPM4

271

Q8TD43
LDMFLQKPLGLLALL

MYO3B

781

Q8WXR4